Replies to post #748897 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Skeptics here always knew that. And, it’s still a big question mark as to the kind of back and forth they’re having with MHRA?? But one thing for sure, “Management” seems intent on using up all their shares so they can ask for more along with another reverse split.

[Doc logic]

LessIsMore,

That quote is already a dated source of information but also comes from the last company update so that is what was used as a best source. You know that an update is expected in the next Q, annual report and possibly from MHRA itself before then. Even Investor082 expects an approval soon and admits that he is adamant this stock is worth buying at this current price compared to a post MHRA decision so take up your doubts with him; ). Best wishes.

[Lykiri]

Reports suggest that the company is still working closely with consultants on matters related to the review, including preparing for upcoming inspections by the MHRA in the U.S. and the U.K.

The author could not confirm that the inspections were still pending and relied on older communications from NWBio dated August 2024. In the updated version, this sentence has been removed, making the information more accurate.

https://www.labiotech.eu/in-depth/dendritic-cell-therapy/